News for 'Sun Pharma'

LIC's stock portfolio sees Rs 46,000 cr dent in July

LIC's stock portfolio sees Rs 46,000 cr dent in July

Rediff.com5 Aug 2025

Life Insurance Corporation (LIC) , the country's largest domestic institutional investor (DII), has seen a Rs 46,000 crore erosion in the value of its equity holdings amid market downturns in July. The benchmark indices, Nifty 50 and BSE Sensex, have slipped 2.6 per cent from their June 2025-end level to 24,837 and 81,463.09 respectively.

Procter & Gamble names Shailesh Jejurikar as CEO

Procter & Gamble names Shailesh Jejurikar as CEO

Rediff.com29 Jul 2025

Procter & Gamble has announced Shailesh Jejurikar as its next CEO, effective January 1, 2026. Jejurikar, an India-born executive, will succeed Jon Moeller in the role.

Sensex decline on fag-end selling; financial stocks drag

Sensex decline on fag-end selling; financial stocks drag

Rediff.com3 Jul 2025

Among the Sensex firms, Kotak Mahindra Bank, Bajaj Finserv, Bajaj Finance, Adani Ports, Trent, State Bank of India, Titan and Tata Consultancy Services were the laggards. However, Maruti, Infosys, NTPC, Asian Paints, Eternal and Hindustan Unilever were among the biggest gainers.

T'gana plant blast: 9 still missing; cause yet to be known

T'gana plant blast: 9 still missing; cause yet to be known

Rediff.com3 Jul 2025

Nine people remain missing following the explosion at the Sigachi Industries' pharma plant in Pashamylaram, Telangana, which claimed 38 lives. An expert committee is investigating the cause of the blast.

Sensex gains 320 points; Nifty ends above 24K

Sensex gains 320 points; Nifty ends above 24K

Rediff.com29 May 2025

Benchmark stock indices Sensex and Nifty rebounded on Thursday after two days of decline, mirroring a rally in global markets as a US court blocked President Donald Trump's reciprocal tariffs. The 30-share BSE Sensex climbed 320.70 points or 0.39 per cent to settle at 81,633.02.

Stock markets end lower amid Israel-Iran conflict, rising crude oil prices

Stock markets end lower amid Israel-Iran conflict, rising crude oil prices

Rediff.com17 Jun 2025

From the Sensex pack, Sun Pharma, Eternal, Tata Motors, Bajaj Finance, IndusInd Bank and Bajaj Finserv were among the major laggards. In contrast, Tech Mahindra, Infosys, Asian Paints and Maruti were among the gainers.

Trump Is Winning Tariff War Hands Down

Trump Is Winning Tariff War Hands Down

Rediff.com18 Aug 2025

Donald Trump's tariffs, meant as political punishment, have avoided the predicted chaos, lifting US growth, weakening rivals, and letting him claim victory in a resilient global economy, observes T T Ram Mohan.

Trump's Tariffs: Why India Needs To Be Strategic

Trump's Tariffs: Why India Needs To Be Strategic

Rediff.com12 Aug 2025

In trade negotiations, as in chess, sometimes you need to accept a temporary disadvantage to secure a better long-term position, points out Sonal Varma, chief economist (India and Asia ex-Japan) at Nomura.

Sensex, Nifty rebound nearly 1% on value buying

Sensex, Nifty rebound nearly 1% on value buying

Rediff.com16 Jun 2025

Among 30 Sensex firms, UltraTech Cement, Tech Mahindra, HCL Tech, Tata Consultancy Services, Eternal, Asian Paints, Tata Steel and Kotak Mahindra Bank were among the biggest gainers. Tata Motors, Adani Ports and Sun Pharma were the laggards.

Sigachi used old machinery despite requests to change, says FIR

Sigachi used old machinery despite requests to change, says FIR

Rediff.com2 Jul 2025

An FIR filed against Sigachi Industries following a fatal explosion at its Telangana unit alleges the company used outdated machinery despite warnings from employees.

Sensex gains 300 pts on fresh foreign fund inflows and buying in ICICI Bank, RIL

Sensex gains 300 pts on fresh foreign fund inflows and buying in ICICI Bank, RIL

Rediff.com27 Jun 2025

From the Sensex pack, Asian Paints, UltraTech Cement, Power Grid, ICICI Bank, Reliance Industries, Hindustan Unilever, Bharat Electronics and Sun Pharma were among the major gainers. In contrast, Trent, Eternal, Axis Bank and Titan were among the laggards.

Weak Q4 may be rare bitter pill for Sun Pharma

Weak Q4 may be rare bitter pill for Sun Pharma

Rediff.com31 May 2024

Sun Pharmaceutical Industries reported a 34 per cent year-on-year (Y-o-Y) jump in net profit to Rs 2,654.6 crore in Q4FY24.

Key factors to drive stock markets this week

Key factors to drive stock markets this week

Rediff.com6 Jul 2025

Equity investors are up for an eventful trading week ahead as the 90-day suspension period of the reciprocal tariffs announced by US President Donald Trump ends on July 9, analysts said, adding that a positive outcome from the trade negotiations could further lift market sentiment, particularly benefiting trade-sensitive sectors.

Sensex drops 345 points on weakness in IT stocks

Sensex drops 345 points on weakness in IT stocks

Rediff.com10 Jul 2025

From the Sensex pack, Bharti Airtel, Asian Paints, Infosys, Bharat Electronics, Tech Mahindra and Eternal were major laggards. However, Maruti, Tata Steel, Bajaj Finance, Bajaj Finserv, Trent and Tata Consultancy Services were among the gainers.

'Will Learning AI Help Me As An Entrepreneur?'

'Will Learning AI Help Me As An Entrepreneur?'

Rediff.com28 May 2025

Dr Ganesh Natarajan, a special guest on rediffGURUS, has been addressing questions from Rediff readers, about how to grow professionally, how women can achieve leadership roles in Indian companies, and what it takes to succeed as an entrepreneur.

Foreign fund inflows, ICICI Bank and RIL boost markets

Foreign fund inflows, ICICI Bank and RIL boost markets

Rediff.com5 Jun 2025

Eternal was the biggest gainer in the Sensex pack, jumping 4.50 per cent, followed by Power Grid, ICICI Bank, Reliance Industries, UltraTech Cement, Adani Ports, Sun Pharma, ITC and Hindustan Unilever were also among the winners. In contrast, IndusInd Bank, Axis Bank, Bajaj Finserv and Bajaj Finance were among the laggards.

Sensex surges over 769 pts as FMCG, power shares gain

Sensex surges over 769 pts as FMCG, power shares gain

Rediff.com23 May 2025

From the Sensex firms, Eternal, Power Grid, ITC, Bajaj Finserv, Nestle, Axis Bank, Kotak Mahindra Bank and Adani Ports were among the biggest gainers. Sun Pharma was the only laggard, declining nearly 2 per cent.

Sensex sinks 573 pts on global tensions and high crude prices

Sensex sinks 573 pts on global tensions and high crude prices

Rediff.com13 Jun 2025

Sensex sinks 573 pts on global tensions and high crude prices

Pharma cos okay with QR codes to combat counterfeit drugs

Pharma cos okay with QR codes to combat counterfeit drugs

Rediff.com19 Jul 2024

As the Drugs Controller General of India (DCGI) is set to crack down on companies to ensure compliance with printing QR codes on top-selling brands to curb counterfeiting, top pharma companies say they welcome the regulator's mandate and that they are on track. They also view it as a positive step to ensure patient safety. Sheetal Arora, CEO of Mankind Pharmaceuticals, which has already adopted QR codes in 20 of their products, stated: "We strongly advocate for mandatory implementation of barcodes and QR codes on medicines as this initiative will not only protect patients but also strengthen the integrity of our healthcare system by reducing circulation of counterfeit drugs."

Sensex ends down 182 points on selling in IT shares

Sensex ends down 182 points on selling in IT shares

Rediff.com30 May 2025

Among Sensex firms, Tech Mahindra, HCL Tech, Asian Paints, NTPC, Infosys, Nestle, Sun Pharma, and Tata Steel were the major laggards. Eternal, State Bank of India, HDFC Bank, Larsen & Toubro, Reliance Industries and Bajaj Finserv were the gainers.

How Kerala Aims to Be India's First Poverty Free State

How Kerala Aims to Be India's First Poverty Free State

Rediff.com14 Jul 2025

Despite facing financial constraints, Kerala has been able to invest in welfare schemes and targeted programmes.

Sensex sheds 239 pts on selling in FMCG, auto shares

Sensex sheds 239 pts on selling in FMCG, auto shares

Rediff.com28 May 2025

IndusInd Bank, Nestle, UltraTech Cement, Mahindra & Mahindra, Power Grid, Asian Paints, Sun Pharma and Tech Mahindra were also among the laggards. Bajaj Finance, Bharti Airtel, ICICI Bank, Adani Ports and HCL Tech were among the gainers.

Jurassic World Rebirth Review: Time Pass

Jurassic World Rebirth Review: Time Pass

Rediff.com4 Jul 2025

As a nothing-better-to-do weekend watch, Jurassic World Rebirth is fine. But the franchise is losing steam, observes Deepa Gahlot.

Diabetes Drug Price Drops 90%

Diabetes Drug Price Drops 90%

Rediff.com20 Mar 2025

India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 crore anti-diabetic drug market in India is growing at 9 per cent or so.

Sensex jumps 410 pts on buying in banking shares

Sensex jumps 410 pts on buying in banking shares

Rediff.com21 May 2025

Among Sensex firms, Bajaj Finserv, Tata Steel, Sun Pharma, Tech Mahindra, Bajaj Finance, NTPC, Nestle, Tata Motors, Hindustan Unilever and Mahindra & Mahindra were the biggest gainers. IndusInd Bank, Kotak Mahindra Bank, Power Grid and ITC were among the laggards.

Sensex gains 318 pts on buying in RIL, L&T

Sensex gains 318 pts on buying in RIL, L&T

Rediff.com27 Mar 2025

From the Sensex pack, Bajaj Finserv, IndusInd Bank, NTPC, Larsen & Toubro, UltraTech Cement, Adani Ports, Bajaj Finance, Power Grid, Zomato, State Bank of India, HDFC Bank and Titan were the biggest gainers. Tata Motors tanked over 5.5 per cent after US President Donald Trump announced he would impose 25 per cent tariffs on imported cars. Sun Pharma, Kotak Mahindra Bank, Bharti Airtel, HCL Tech and Mahindra & Mahindra were also among the laggards.

Margin pressures, growth triggers to weigh on Dr Reddy's

Margin pressures, growth triggers to weigh on Dr Reddy's

Rediff.com21 May 2025

Pharma major Dr Reddy's Laboratories delivered a muted operational performance in the fourth quarter of financial year 2024-25 (Q4FY25), even as revenue growth remained healthy. Lower gross margin performance and muted domestic growth are key concerns. Most brokerages have a "Sell" or "Reduce" rating as there are uncertainties related to the development of a new product portfolio and the launch timelines.

Telangana plant explosion toll rises to 36; FIR against factory mgmt

Telangana plant explosion toll rises to 36; FIR against factory mgmt

Rediff.com1 Jul 2025

The death toll from the explosion at the Sigachi Industries' pharma plant in Pashamylaram has risen to 35, police said on Tuesday.

Exports fall 2.17% in May; trade deficit narrows

Exports fall 2.17% in May; trade deficit narrows

Rediff.com16 Jun 2025

After registering a positive growth for two months, India's exports slipped into negative territory again, contracting 2.17 per cent year-on-year to $38.73 billion in May due to a fall in global petroleum prices, while trade deficit narrowed at $21.88 billion during the month.

Indian pharma companies bank on 'mother brands' to boost revenue growth

Indian pharma companies bank on 'mother brands' to boost revenue growth

Rediff.com28 Mar 2024

Indian pharma companies are focussing on flagship products or mother brands under which they launch various new combinations to ensure robust revenue growth as well as therapy leadership. An analysis by market research firm Pharmarack showed how such flagship brands have posted strong growth CAGR in the last five years, with some even doubling sales. Sheetal Sapale, vice-president, commercial at Pharmarack, said, "Mother brands are analogous to an aggressive player who has put in a lot of effort during the prime years of life but now continues to silently nurture the brand family to collectively cross newer benchmarks of success."

Sun Pharma's growth pill: Specialising in specialty and scaling in India

Sun Pharma's growth pill: Specialising in specialty and scaling in India

Rediff.com25 Mar 2024

Traction for its specialty portfolio, a strong showing in the domestic market, and better regulatory compliance are positives for the country's largest pharmaceutical (pharma) company, Sun Pharmaceutical Industries. Given the triggers, some brokerages have increased their earnings per share estimates and target price for 2024-25 (FY25). This should sustain the momentum for the stock, which has been one of the major pharma gainers in 2023-24 (FY24), rising 57 per cent. It is currently trading at Rs 1,547 per share.

Sensex jumps 1,006 pts on buying in RIL, foreign fund inflows

Sensex jumps 1,006 pts on buying in RIL, foreign fund inflows

Rediff.com28 Apr 2025

Sun Pharma, Tata Steel, State Bank of India, Axis Bank, Tata Motors, Larsen & Toubro and ICICI Bank were also among the Sensex gainers. HCL Tech, UltraTech Cement, Nestle and Hindustan Unilever were among the laggards.

Markets slump over 1%; Sensex tanks 1,282 points

Markets slump over 1%; Sensex tanks 1,282 points

Rediff.com13 May 2025

From the Sensex firms, Infosys declined by 3.54 per cent. Power Grid, Eternal, HCL Tech, Tata Consultancy Services, Bharti Airtel, IndusInd Bank, NTPC and HDFC Bank were the major laggards. Sun Pharma, Adani Ports, Bajaj Finance, State Bank of India and Tech Mahindra were the gainers.

India hasn't accepted UK 'data exclusivity' demand in FTA

India hasn't accepted UK 'data exclusivity' demand in FTA

Rediff.com12 May 2025

India has not accepted the demand of the UK for inclusion of a 'data exclusivity' provision in the free trade agreement, announced on May 6, in a bid to protect the interests of the domestic generic drugs industry, an official said. During the negotiations, the UK had asked to include this provision in the trade pact.

Foreign brokerages stay cautious on India stock market

Foreign brokerages stay cautious on India stock market

Rediff.com10 Jun 2025

Foreign brokerages remain cautious on the road ahead for the Indian equity markets. Though analysts at Nomura have revised their March 2026 Nifty target to 26,140 levels from the earlier 24,970, but the upside from the current levels is a modest 6 per cent. BofA Securities, on the other hand, has not made any change to its year-end Nifty target.

Liverpool Univ to Open Bengaluru Campus

Liverpool Univ to Open Bengaluru Campus

Rediff.com27 May 2025

Initially, we will look to take a small batch of a few hundred students, with a plan to increase this to 5,000 students in the next five years, and eventually 10,000 by 2036.'

Exports inch up; trade deficit hits $21.54 bn in March

Exports inch up; trade deficit hits $21.54 bn in March

Rediff.com16 Apr 2025

India's exports grew marginally by 0.7 per cent to $41.97 billion in March, while the trade deficit stood at $21.54 billion in the month, the latest government data showed on Tuesday.

Sensex climbs 70 points on foreign fund inflows

Sensex climbs 70 points on foreign fund inflows

Rediff.com29 Apr 2025

From the Sensex firms, Reliance Industries, Tech Mahindra, Eternal, HCL Tech, Infosys, IndusInd Bank, Tata Consultancy Services and Bajaj Finserv were the biggest gainers. In contrast, UltraTech Cement, Sun Pharma, Power Grid, NTPC, Kotak Mahindra Bank and Mahindra & Mahindra were among the laggards.

Sensex jumps over 700 points, Nifty reclaims 25,000

Sensex jumps over 700 points, Nifty reclaims 25,000

Rediff.com6 Jun 2025

Maruti, IndusInd Bank, Bajaj Finserv, Eternal, Mahindra & Mahindra, Tata Steel, Kotak Mahindra Bank, Titan, HDFC Bank, and NTPC were among the other major gainers. Bharti Airtel and Sun Pharma were the laggards.

Factors that will drive the markets this week

Factors that will drive the markets this week

Rediff.com25 May 2025

Movement in the equity market this week will be guided by a host of macroeconomic data announcements, global trends and trading activity of foreign investors, analysts said. Stocks markets concluded the last week on a subdued note, as investors grappled with global uncertainties.